Anamorelin manufacturers and listing information

Anamorelin (Anamorelin), also known as Adlumiz, is a drug used to treat cancer cachexia in patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, colorectal cancer and other malignant tumors. Cancer cachexia is a common complication of cancer that can lead to serious problems such as weight loss, loss of appetite, and malnutrition, thereby impairing patients' quality of life and treatment response. Anamorelin, as a new type of selective ghrelin receptor agonist, can improve the weight loss and loss of appetite in patients with cancer cachexia by simulating the ghrelin secreted by the gastrointestinal tract.

There are two main manufacturers of Anamorelin: One is Ono Pharmaceuticals of Japan, and the other is Lucius Pharmaceuticals of Laos. Anamorelin produced by Ono Pharmaceutical was first launched in Japan in 2021, filling the gap in drug treatment of cancer cachexia. The specification of this medicine is 50mg*100 tablets/box, and the price is about 4,000 yuan. The generic version of Anamorelin produced by Lucius Pharmaceuticals was subsequently approved by the Lao government and sold on the Lao market. The price of this version is more affordable, about more than 2,000 yuan, providing more choices for patients with limited financial conditions.

It is worth noting that although anamorelin has been marketed in Japan and has achieved good clinical results, as of the current time, it has not yet received marketing approval in China. Therefore, if domestic patients need to use anamorelin, they may need to purchase it from overseas through formal and legal means. When purchasing, patients should make sure to choose formal channels and carefully check the production batch number and expiration date of the drug to ensure the quality and safety of the drug.

In short, as an effective drug for treating cancer cachexia, anamorelin has different manufacturers and marketing information in different countries and regions. When obtaining and using this drug, patients should carefully understand the relevant information and use it rationally under the guidance of a doctor to ensure therapeutic effect and safety.

References:

https://www.helsinn.com/products/adlumiz/